RPG Life Sciences
BSE 532983
5 stories, newest first.
- RPG Life Sciences to hold Q2 FY27 results earnings call on October 30, 2026 at 5:00 PM IST
- Board Meeting on October 29, 2026 to Approve Q2 and H1 Results
- RPG Life Sciences Ltd shareholder buys 0.23% stake, holding rises to 7.04%
- Subsidiary Board Approves Amalgamation of Actis Generics with RPG Active Pharma
- Acquisition of Actis Generics Completed; Becomes Subsidiary
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.